We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Predicting the Extent of Prostate Cancer Using a Combination of Serum Prostate-Specific Antigen-Alpha[sub 1] -Antichymotrypsin Complex and Systematic Biopsy.
- Authors
Miyake, Hideaki; Hara, Shoji; Yamanaka, Nozomu; Ono, Yoshiharu; Eto, Hiroshi; Yamada, Yuji; Takechi, Yoshizumi; Arakawa, Soichi; Kamidono, Sadao; Hara, Isao
- Abstract
Objective: The objective of the present study was to evaluate the usefulness of the combined systematic biopsy with serum prostate-specific antigen-α[sub 1] -antichymotrypsin complex (PSA-ACT) level to predict the extent of prostate cancer. Materials and Methods: Sixty-two patients with clinically organ-confined disease who underwent radical prostatectomy were evaluated for serum PSA and PSA-ACT levels, systematic biopsy, and the pathological stage. Results: The incidence of extraprostatic disease in patients with more than half the biopsy cores positive or ≥8 ng/ml PSA-ACT was significantly higher than those with less than half positive or <8 ng/ml PSA-ACT, respectively, whereas cancer in bilateral lobes or ≥10 ng/ml PSA could not be used as a predictor of extraprostatic disease. Furthermore, in those with more than half the biopsy cores positive and ≥8 ng/ml PSA-ACT or those with more than half the biopsy cores positive and ≥10 ng/ml PSA, extraprostatic disease was significantly more common than in those with less than half positive and <8 ng/ml PSA-ACT or those with less than half positive and <10 ng/ml PSA, respectively. However, the incidence of extraprostatic disease predicted by these three variables was not significantly better than those by the two variables (percentage positive biopsy cores plus serum PSA-ACT or PSA). Conclusions: The combined systematic biopsy with serum PSA-ACT or PSA could be used as a useful predictor for the extent of prostate cancer. Patients with more than half the biopsy cores positive and ≥8 ng/ml PSA-ACT or ≥10 ng/ml PSA could avoid a prostatectomy because there is a high probability that they have extraprostatic disease.Copyright © 2002 S. Karger AG, Basel
- Subjects
PROSTATE; CANCER; SERUM; ANTIGENS; BIOPSY
- Publication
Urologia Internationalis, 2002, Vol 68, Issue 4, p232
- ISSN
0042-1138
- Publication type
Article
- DOI
10.1159/000058441